Exploring low mood in a person with cancer
What you need to know Psychological, rather than biological, symptoms of depression, such as anhedonia and pronounced helplessness, hopelessness, guilt, and suicidal ideation, tend to be key diagnostic pointers to depression in patients with cancer Anxiety is regarded as pathological in a patient wi...
Gespeichert in:
Veröffentlicht in: | BMJ (Online) 2018-04, Vol.361, p.k1488-k1488 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | k1488 |
---|---|
container_issue | |
container_start_page | k1488 |
container_title | BMJ (Online) |
container_volume | 361 |
creator | Pitman, Alexandra Suleman, Sahil Hyde, Nicholas Hodgkiss, Andrew |
description | What you need to know Psychological, rather than biological, symptoms of depression, such as anhedonia and pronounced helplessness, hopelessness, guilt, and suicidal ideation, tend to be key diagnostic pointers to depression in patients with cancer Anxiety is regarded as pathological in a patient with cancer when it is disproportionate to the level of threat and disrupts usual functioning Investigate and address reversible causes, such as vitamin deficiency or hypercalcaemia, and perpetuating factors, such as pain A 54 year old man asks his doctor for a sleeping tablet.Risk factors for suicide in cancer include tumour site, physical functioning, and cancer prognosis, in addition to the usual risk factors for completed suicide in the general population. 5 Patients with head and neck tumours, multiple myeloma, or lung cancer and those with limited treatment options are a particular concern, as are men with poor social support. 6 Suicide risk peaks during the first month after cancer diagnosis. 7 Such elevated risks are apparent despite the prevalence of suicidal ideation being no higher than that in the general population. 5 Suicidal thoughts may arise as a catastrophic reaction to a new diagnosis, during the intense phase of treatment, or in terminal illness ( box 1 ).If a person asks about options for hastening their death, use their request to open up a conversation about their fears about death Explore modifiable contributory factors, particularly pain Clarify that assistance to die cannot be provided, document the discussion, and explain your obligation to share their feelings with senior professional colleagues Clinical examination Whether the aetiology is thought to be biopsychosocial or due to direct biological effects (for example, due to recent antifolate chemotherapy), a full physical screen will identify any reversible contributory causes.[...]interventions include anxiety management or cognitive-behavioural therapy tailored to cancer contexts, and are provided in specialist psychological support services, including specialist counsellors and clinical psychologists embedded in cancer services. 9 Patients with cancer treated in primary care for major depression have better response rates to antidepressants after prescribing input from a psychiatrist. 10 Liaison psychiatrists have particular expertise in selecting antidepressants in the context of complex medical or surgical care, particularly in the case of treatment resistance. |
doi_str_mv | 10.1136/bmj.k1488 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2031417095</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2031417095</sourcerecordid><originalsourceid>FETCH-LOGICAL-b377t-930a52adfcdb9c6dd85c35b901ec548370ff22e22483197299637191709d50bf3</originalsourceid><addsrcrecordid>eNp10MtKAzEUBuAgii21C19AArpQYWouzW0ppV6g4EbXIZPJ6NSZyZh0qL69GasuBFc5i-_8J_wAHGM0w5jyq7xZz17xXMo9MMaC8QxLSvfBGCmmMompHIFpjGuEEKFCKs4OwYgorthckjG4XL53tQ9V-wxrv4WN9wWsWmhg50L0LdxWmxdoTWtdOAIHpamjm36_E_B0s3xc3GWrh9v7xfUqy6kQm0xRZBgxRWmLXFleFJJZynKFsLPpJhWoLAlxhKQZK0GU4lRghQVSBUN5SSfgfJfbBf_Wu7jRTRWtq2vTOt9HTRDF84GzRE__0LXvQ5t-NyjEMUOcJ3WxUzb4GIMrdReqxoQPjZEeOtSpQ_3VYbIn34l93rjiV_40lsDZDgw7_-d8AqsZdMI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2030615066</pqid></control><display><type>article</type><title>Exploring low mood in a person with cancer</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><creator>Pitman, Alexandra ; Suleman, Sahil ; Hyde, Nicholas ; Hodgkiss, Andrew</creator><creatorcontrib>Pitman, Alexandra ; Suleman, Sahil ; Hyde, Nicholas ; Hodgkiss, Andrew</creatorcontrib><description>What you need to know Psychological, rather than biological, symptoms of depression, such as anhedonia and pronounced helplessness, hopelessness, guilt, and suicidal ideation, tend to be key diagnostic pointers to depression in patients with cancer Anxiety is regarded as pathological in a patient with cancer when it is disproportionate to the level of threat and disrupts usual functioning Investigate and address reversible causes, such as vitamin deficiency or hypercalcaemia, and perpetuating factors, such as pain A 54 year old man asks his doctor for a sleeping tablet.Risk factors for suicide in cancer include tumour site, physical functioning, and cancer prognosis, in addition to the usual risk factors for completed suicide in the general population. 5 Patients with head and neck tumours, multiple myeloma, or lung cancer and those with limited treatment options are a particular concern, as are men with poor social support. 6 Suicide risk peaks during the first month after cancer diagnosis. 7 Such elevated risks are apparent despite the prevalence of suicidal ideation being no higher than that in the general population. 5 Suicidal thoughts may arise as a catastrophic reaction to a new diagnosis, during the intense phase of treatment, or in terminal illness ( box 1 ).If a person asks about options for hastening their death, use their request to open up a conversation about their fears about death Explore modifiable contributory factors, particularly pain Clarify that assistance to die cannot be provided, document the discussion, and explain your obligation to share their feelings with senior professional colleagues Clinical examination Whether the aetiology is thought to be biopsychosocial or due to direct biological effects (for example, due to recent antifolate chemotherapy), a full physical screen will identify any reversible contributory causes.[...]interventions include anxiety management or cognitive-behavioural therapy tailored to cancer contexts, and are provided in specialist psychological support services, including specialist counsellors and clinical psychologists embedded in cancer services. 9 Patients with cancer treated in primary care for major depression have better response rates to antidepressants after prescribing input from a psychiatrist. 10 Liaison psychiatrists have particular expertise in selecting antidepressants in the context of complex medical or surgical care, particularly in the case of treatment resistance.</description><identifier>ISSN: 0959-8138</identifier><identifier>EISSN: 1756-1833</identifier><identifier>DOI: 10.1136/bmj.k1488</identifier><identifier>PMID: 29695482</identifier><language>eng</language><publisher>England: BMJ Publishing Group LTD</publisher><subject>Antidepressive Agents - therapeutic use ; Anxiety ; Anxiety - diagnosis ; Anxiety - etiology ; Anxiety - therapy ; Cancer ; Chemotherapy ; Cognitive Behavioral Therapy ; Depression - diagnosis ; Depression - etiology ; Depression - therapy ; Family medical history ; Head & neck cancer ; Health risk assessment ; Humans ; Hypercalcemia ; Lung cancer ; Medical diagnosis ; Medical History Taking - methods ; Medical prognosis ; Mental depression ; Mental health ; Mood ; Neoplasms - psychology ; Oncology ; Pain ; Patients ; Practice Guidelines as Topic ; Referral and Consultation ; Risk Assessment ; Suicides & suicide attempts ; Vitamin deficiency</subject><ispartof>BMJ (Online), 2018-04, Vol.361, p.k1488-k1488</ispartof><rights>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to</rights><rights>Copyright: 2018 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b377t-930a52adfcdb9c6dd85c35b901ec548370ff22e22483197299637191709d50bf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29695482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pitman, Alexandra</creatorcontrib><creatorcontrib>Suleman, Sahil</creatorcontrib><creatorcontrib>Hyde, Nicholas</creatorcontrib><creatorcontrib>Hodgkiss, Andrew</creatorcontrib><title>Exploring low mood in a person with cancer</title><title>BMJ (Online)</title><addtitle>BMJ</addtitle><description>What you need to know Psychological, rather than biological, symptoms of depression, such as anhedonia and pronounced helplessness, hopelessness, guilt, and suicidal ideation, tend to be key diagnostic pointers to depression in patients with cancer Anxiety is regarded as pathological in a patient with cancer when it is disproportionate to the level of threat and disrupts usual functioning Investigate and address reversible causes, such as vitamin deficiency or hypercalcaemia, and perpetuating factors, such as pain A 54 year old man asks his doctor for a sleeping tablet.Risk factors for suicide in cancer include tumour site, physical functioning, and cancer prognosis, in addition to the usual risk factors for completed suicide in the general population. 5 Patients with head and neck tumours, multiple myeloma, or lung cancer and those with limited treatment options are a particular concern, as are men with poor social support. 6 Suicide risk peaks during the first month after cancer diagnosis. 7 Such elevated risks are apparent despite the prevalence of suicidal ideation being no higher than that in the general population. 5 Suicidal thoughts may arise as a catastrophic reaction to a new diagnosis, during the intense phase of treatment, or in terminal illness ( box 1 ).If a person asks about options for hastening their death, use their request to open up a conversation about their fears about death Explore modifiable contributory factors, particularly pain Clarify that assistance to die cannot be provided, document the discussion, and explain your obligation to share their feelings with senior professional colleagues Clinical examination Whether the aetiology is thought to be biopsychosocial or due to direct biological effects (for example, due to recent antifolate chemotherapy), a full physical screen will identify any reversible contributory causes.[...]interventions include anxiety management or cognitive-behavioural therapy tailored to cancer contexts, and are provided in specialist psychological support services, including specialist counsellors and clinical psychologists embedded in cancer services. 9 Patients with cancer treated in primary care for major depression have better response rates to antidepressants after prescribing input from a psychiatrist. 10 Liaison psychiatrists have particular expertise in selecting antidepressants in the context of complex medical or surgical care, particularly in the case of treatment resistance.</description><subject>Antidepressive Agents - therapeutic use</subject><subject>Anxiety</subject><subject>Anxiety - diagnosis</subject><subject>Anxiety - etiology</subject><subject>Anxiety - therapy</subject><subject>Cancer</subject><subject>Chemotherapy</subject><subject>Cognitive Behavioral Therapy</subject><subject>Depression - diagnosis</subject><subject>Depression - etiology</subject><subject>Depression - therapy</subject><subject>Family medical history</subject><subject>Head & neck cancer</subject><subject>Health risk assessment</subject><subject>Humans</subject><subject>Hypercalcemia</subject><subject>Lung cancer</subject><subject>Medical diagnosis</subject><subject>Medical History Taking - methods</subject><subject>Medical prognosis</subject><subject>Mental depression</subject><subject>Mental health</subject><subject>Mood</subject><subject>Neoplasms - psychology</subject><subject>Oncology</subject><subject>Pain</subject><subject>Patients</subject><subject>Practice Guidelines as Topic</subject><subject>Referral and Consultation</subject><subject>Risk Assessment</subject><subject>Suicides & suicide attempts</subject><subject>Vitamin deficiency</subject><issn>0959-8138</issn><issn>1756-1833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10MtKAzEUBuAgii21C19AArpQYWouzW0ppV6g4EbXIZPJ6NSZyZh0qL69GasuBFc5i-_8J_wAHGM0w5jyq7xZz17xXMo9MMaC8QxLSvfBGCmmMompHIFpjGuEEKFCKs4OwYgorthckjG4XL53tQ9V-wxrv4WN9wWsWmhg50L0LdxWmxdoTWtdOAIHpamjm36_E_B0s3xc3GWrh9v7xfUqy6kQm0xRZBgxRWmLXFleFJJZynKFsLPpJhWoLAlxhKQZK0GU4lRghQVSBUN5SSfgfJfbBf_Wu7jRTRWtq2vTOt9HTRDF84GzRE__0LXvQ5t-NyjEMUOcJ3WxUzb4GIMrdReqxoQPjZEeOtSpQ_3VYbIn34l93rjiV_40lsDZDgw7_-d8AqsZdMI</recordid><startdate>20180425</startdate><enddate>20180425</enddate><creator>Pitman, Alexandra</creator><creator>Suleman, Sahil</creator><creator>Hyde, Nicholas</creator><creator>Hodgkiss, Andrew</creator><general>BMJ Publishing Group LTD</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20180425</creationdate><title>Exploring low mood in a person with cancer</title><author>Pitman, Alexandra ; Suleman, Sahil ; Hyde, Nicholas ; Hodgkiss, Andrew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b377t-930a52adfcdb9c6dd85c35b901ec548370ff22e22483197299637191709d50bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antidepressive Agents - therapeutic use</topic><topic>Anxiety</topic><topic>Anxiety - diagnosis</topic><topic>Anxiety - etiology</topic><topic>Anxiety - therapy</topic><topic>Cancer</topic><topic>Chemotherapy</topic><topic>Cognitive Behavioral Therapy</topic><topic>Depression - diagnosis</topic><topic>Depression - etiology</topic><topic>Depression - therapy</topic><topic>Family medical history</topic><topic>Head & neck cancer</topic><topic>Health risk assessment</topic><topic>Humans</topic><topic>Hypercalcemia</topic><topic>Lung cancer</topic><topic>Medical diagnosis</topic><topic>Medical History Taking - methods</topic><topic>Medical prognosis</topic><topic>Mental depression</topic><topic>Mental health</topic><topic>Mood</topic><topic>Neoplasms - psychology</topic><topic>Oncology</topic><topic>Pain</topic><topic>Patients</topic><topic>Practice Guidelines as Topic</topic><topic>Referral and Consultation</topic><topic>Risk Assessment</topic><topic>Suicides & suicide attempts</topic><topic>Vitamin deficiency</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pitman, Alexandra</creatorcontrib><creatorcontrib>Suleman, Sahil</creatorcontrib><creatorcontrib>Hyde, Nicholas</creatorcontrib><creatorcontrib>Hodgkiss, Andrew</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>BMJ (Online)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pitman, Alexandra</au><au>Suleman, Sahil</au><au>Hyde, Nicholas</au><au>Hodgkiss, Andrew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploring low mood in a person with cancer</atitle><jtitle>BMJ (Online)</jtitle><addtitle>BMJ</addtitle><date>2018-04-25</date><risdate>2018</risdate><volume>361</volume><spage>k1488</spage><epage>k1488</epage><pages>k1488-k1488</pages><issn>0959-8138</issn><eissn>1756-1833</eissn><abstract>What you need to know Psychological, rather than biological, symptoms of depression, such as anhedonia and pronounced helplessness, hopelessness, guilt, and suicidal ideation, tend to be key diagnostic pointers to depression in patients with cancer Anxiety is regarded as pathological in a patient with cancer when it is disproportionate to the level of threat and disrupts usual functioning Investigate and address reversible causes, such as vitamin deficiency or hypercalcaemia, and perpetuating factors, such as pain A 54 year old man asks his doctor for a sleeping tablet.Risk factors for suicide in cancer include tumour site, physical functioning, and cancer prognosis, in addition to the usual risk factors for completed suicide in the general population. 5 Patients with head and neck tumours, multiple myeloma, or lung cancer and those with limited treatment options are a particular concern, as are men with poor social support. 6 Suicide risk peaks during the first month after cancer diagnosis. 7 Such elevated risks are apparent despite the prevalence of suicidal ideation being no higher than that in the general population. 5 Suicidal thoughts may arise as a catastrophic reaction to a new diagnosis, during the intense phase of treatment, or in terminal illness ( box 1 ).If a person asks about options for hastening their death, use their request to open up a conversation about their fears about death Explore modifiable contributory factors, particularly pain Clarify that assistance to die cannot be provided, document the discussion, and explain your obligation to share their feelings with senior professional colleagues Clinical examination Whether the aetiology is thought to be biopsychosocial or due to direct biological effects (for example, due to recent antifolate chemotherapy), a full physical screen will identify any reversible contributory causes.[...]interventions include anxiety management or cognitive-behavioural therapy tailored to cancer contexts, and are provided in specialist psychological support services, including specialist counsellors and clinical psychologists embedded in cancer services. 9 Patients with cancer treated in primary care for major depression have better response rates to antidepressants after prescribing input from a psychiatrist. 10 Liaison psychiatrists have particular expertise in selecting antidepressants in the context of complex medical or surgical care, particularly in the case of treatment resistance.</abstract><cop>England</cop><pub>BMJ Publishing Group LTD</pub><pmid>29695482</pmid><doi>10.1136/bmj.k1488</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0959-8138 |
ispartof | BMJ (Online), 2018-04, Vol.361, p.k1488-k1488 |
issn | 0959-8138 1756-1833 |
language | eng |
recordid | cdi_proquest_miscellaneous_2031417095 |
source | Jstor Complete Legacy; MEDLINE |
subjects | Antidepressive Agents - therapeutic use Anxiety Anxiety - diagnosis Anxiety - etiology Anxiety - therapy Cancer Chemotherapy Cognitive Behavioral Therapy Depression - diagnosis Depression - etiology Depression - therapy Family medical history Head & neck cancer Health risk assessment Humans Hypercalcemia Lung cancer Medical diagnosis Medical History Taking - methods Medical prognosis Mental depression Mental health Mood Neoplasms - psychology Oncology Pain Patients Practice Guidelines as Topic Referral and Consultation Risk Assessment Suicides & suicide attempts Vitamin deficiency |
title | Exploring low mood in a person with cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T06%3A13%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploring%20low%20mood%20in%20a%20person%20with%20cancer&rft.jtitle=BMJ%20(Online)&rft.au=Pitman,%20Alexandra&rft.date=2018-04-25&rft.volume=361&rft.spage=k1488&rft.epage=k1488&rft.pages=k1488-k1488&rft.issn=0959-8138&rft.eissn=1756-1833&rft_id=info:doi/10.1136/bmj.k1488&rft_dat=%3Cproquest_cross%3E2031417095%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2030615066&rft_id=info:pmid/29695482&rfr_iscdi=true |